ORAGENICS INC (17)
Browse by Contract Category
Contracts
-
Sales Agent Agreement dated February 1, 2021
(Filed With SEC on February 1, 2021)
-
Form of Securities Purchase Agreement
(Filed With SEC on December 28, 2020)
-
Placement Agent Agreement dated December 23, 2020
(Filed With SEC on December 28, 2020)
-
Non-exclusive intellectual property and biological materials license agreement with the National Institute of Allergy and Infectious Diseases, an institute within the National...
(Filed With SEC on August 14, 2020)
-
Second Amendment to Employment Agreement between the Company and Alan Joslyn effective June 6, 2020
(Filed With SEC on June 5, 2020)
-
Second Amendment to Lease Agreement between the Company and Hawley-Wiggins LLC dated July 13, 2014 (13700 Progress Blvd, Alachua, FL 32615)
(Filed With SEC on March 4, 2020)
-
Underwriting Agreement dated November 19, 2020
(Filed With SEC on November 24, 2020)
-
Warrant, dated May 1, 2020
(Filed With SEC on May 4, 2020)
-
Stock Purchase Agreement, dated May 1, 2020
(Filed With SEC on May 4, 2020)
-
Form of Notice of Grant of Stock Options and Stock Option Award Agreement (Directors)
(Filed With SEC on March 4, 2020)
-
Notice of Assignment of Lantibiotic ECC and Lantibiotic SIA by and between Oragenics, Inc. and Intrexon Corporation (n/k/a Precigen Inc.) to ILH Holdings Inc. effective January 1,...
(Filed With SEC on March 4, 2020)
-
Description of the Registrants Securities Registered Pursuant to Section 12 of the Securities Exchange Act Of 1934
(Filed With SEC on March 4, 2020)
-
Fourth Amendment to 2012 Equity Incentive Plan
(Filed With SEC on June 21, 2019)
-
Specimen Stock Certificate
(Filed With SEC on March 29, 2019)
-
Underwriting Agreement dated March 21, 2019
(Filed With SEC on March 25, 2019)
-
Form of Series 2 Warrant
(Filed With SEC on March 25, 2019)
-
Form of Series 1 Warrant
(Filed With SEC on March 25, 2019)
